» Articles » PMID: 36197636

Progression from Prediabetes to Type 2 Diabetes Mellitus Induced by Overnutrition

Overview
Specialty Endocrinology
Date 2022 Oct 5
PMID 36197636
Authors
Affiliations
Soon will be listed here.
Abstract

Prediabetes has developed into a global pandemic, its prevalence increasing year by year. Although lifestyle changes are advocated as the basis for prediabetes treatment, some patients fail to choose or adhere to appropriate interventions. The basis for selecting an appropriate intervention is determining the stage and cause of the disease. In this review, we aimed to examine the various types and disease processes of prediabetes caused by overnutrition, the present review supporting the hypothesis that overnutrition-induced hyperinsulinemia precedes insulin resistance (IR) and independently causes β-cell dysfunction. Tissue insulin resistance is the main feature of prediabetes with the crosstalk between tissues promoting the formation of systemic insulin resistance. Finally, both β-cell dysfunction induced by hyperinsulinemia or IR and reduced β-cell mass can lead to abnormal insulin secretion and contribute to development of type 2 diabetes mellitus (T2DM). Hence, overnutrition can cause multiple prediabetes phenotypes resulting in development of T2DM through different trajectories. Future diagnosis and treatment should therefore more carefully consider the disease phenotype and stage of development in patients with prediabetes to reduce the incidence of T2DM.

Citing Articles

Nursing interventions guided by the theory of stress and adaptation improve the self-management ability of T2DM patients.

Xin H, Feng J, Zhou B, Ouyang F, Shao H, Xia C Am J Transl Res. 2025; 16(12):7734-7741.

PMID: 39822523 PMC: 11733344. DOI: 10.62347/NBKN4311.


Efficacy and safety of orlistat in controlling the progression of prediabetes to diabetes: A meta-analysis and systematic review.

Gao Z, Huang M, Wang J, Jia H, Lv P, Zeng J Medicine (Baltimore). 2024; 103(21):e38354.

PMID: 38787971 PMC: 11124680. DOI: 10.1097/MD.0000000000038354.


Whole transcriptome sequencing analyses of islets reveal ncRNA regulatory networks underlying impaired insulin secretion and increased β-cell mass in high fat diet-induced diabetes mellitus.

Ma J, Gao R, Xie Q, Pan X, Tong N PLoS One. 2024; 19(4):e0300965.

PMID: 38557554 PMC: 10984535. DOI: 10.1371/journal.pone.0300965.


The Effect of Theaflavins on the Gut Microbiome and Metabolites in Diabetic Mice.

Wang J, Qin Y, Jiang J, Shan H, Zhao C, Li S Foods. 2023; 12(20).

PMID: 37893758 PMC: 10606624. DOI: 10.3390/foods12203865.


Vitamin D supplementation alleviates insulin resistance in prediabetic rats by modifying IRS-1 and PPARγ/NF-κB expressions.

Krisnamurti D, Louisa M, Poerwaningsih E, Tarigan T, Soetikno V, Wibowo H Front Endocrinol (Lausanne). 2023; 14:1089298.

PMID: 37324274 PMC: 10266204. DOI: 10.3389/fendo.2023.1089298.


References
1.
Samocha-Bonet D, Debs S, Greenfield J . Prevention and Treatment of Type 2 Diabetes: A Pathophysiological-Based Approach. Trends Endocrinol Metab. 2018; 29(6):370-379. DOI: 10.1016/j.tem.2018.03.014. View

2.
Bansal N . Prediabetes diagnosis and treatment: A review. World J Diabetes. 2015; 6(2):296-303. PMC: 4360422. DOI: 10.4239/wjd.v6.i2.296. View

3.
Herman W, Pan Q, Edelstein S, Mather K, Perreault L, Barrett-Connor E . Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation. Diabetes Care. 2017; 40(12):1668-1677. PMC: 5711336. DOI: 10.2337/dc17-1116. View

4.
Goodpaster B, Sparks L . Metabolic Flexibility in Health and Disease. Cell Metab. 2017; 25(5):1027-1036. PMC: 5513193. DOI: 10.1016/j.cmet.2017.04.015. View

5.
Esser N, Utzschneider K, Kahn S . Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia. 2020; 63(10):2007-2021. DOI: 10.1007/s00125-020-05245-x. View